Neo Ivy Capital Management Quest Diagnostics Inc Transaction History

Neo Ivy Capital Management

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 29, 2023	BUY	$121.86 - $144.92 $658,531 - $783,147	5,404 New	5,404 $659,000
Q3 2022 Nov 15, 2022	BUY	$121.77 - $141.1 $2,435 - $2,822	20 New	20 $2,000
Q2 2022 Aug 16, 2022	SELL	$127.07 - $145.39 $58,706 - $67,170	-462 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$129.09 - $164.35 $39,114 - $49,798	303 Added 190.57%	462 $64,000
Q4 2021 Feb 15, 2022	SELL	$140.36 - $173.01 $145,553 - $179,411	-1,037 Reduced 86.71%	159 $27,000
Q3 2021 Nov 16, 2021	BUY	$132.95 - $158.0 $159,008 - $188,968	1,196 New	1,196 $136,000
Q2 2021 Aug 16, 2021	SELL	$126.66 - $141.48 $5,573 - $6,225	-44 Closed	0 $0
Q1 2021 Oct 07, 2021	SELL	$114.63 - $133.34 $558,362 - $649,499	-4,871 Reduced 99.1%	44 $6,000
Q4 2020 Feb 16, 2021	BUY	$112.7 - $128.05 $531,155 - $603,499	4,713 Added 2333.17%	4,915 $586,000
Q3 2020 Nov 17, 2020	SELL	$107.05 - $130.01 $176,953 - $214,906	-1,653 Reduced 89.11%	202 $23,000
Q2 2020 Aug 17, 2020	BUY	$73.34 - $122.61 $48,331 - $80,799	659 Added 55.1%	1,855 $211,000
Q2 2020 Aug 17, 2020	SELL	$73.34 - $122.61 $55,225 - $92,325	-753 Reduced 38.64%	1,196 $136,000
Q1 2020 May 15, 2020	BUY	$75.14 - $115.68 $146,447 - $225,460	1,949 New	1,949 $157,000
Q3 2019 Nov 21, 2019	SELL	$97.85 - $107.42 $181,511 - $199,264	-1,855 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$85.18 - $101.94 $158,008 - $189,098	1,855 New	1,855 $189,000

933

93.8M

501K

238K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.